International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
-
Publication Venue For
- Absolute temperature imaging using intermolecular multiple quantum MRI.. 26:725-734. 2010
- Erratum: Arrhenius relationships from the molecule and cell to the clinic (International Journal of Hyperthermia (2009) 25 (21-24)). 25:248. 2009
- The International Journal of Hyperthermia - The first 25 years. 25:1-2. 2009
- Temperature sensitive peptides: engineering hyperthermia-directed therapeutics.. 24:483-495. 2008
- Future directions in regional treatment strategies for melanoma and sarcoma.. 24:301-309. 2008
- Pharmacokinetics & drug resistance of melphalan in regional chemotherapy: ILP versus ILI.. 24:239-249. 2008
- Rationale for and measurement of liposomal drug delivery with hyperthermia using non-invasive imaging techniques.. 24:79-90. 2008
- Letter to the editor. 24:604-604. 2008
- State of the journal, 2007. 23:607-608. 2007
- Online feedback focusing algorithm for hyperthermia cancer treatment.. 23:539-554. 2007
- A note from the Editor-in-Chief. 23:1-2. 2007
- Anti-angiogenic effects of interleukin-12 delivered by a novel hyperthermia induced gene construct.. 22:587-606. 2006
- Changes in tumour oxygenation during fractionated hyperthermia and radiation therapy in spontaneous canine sarcomas.. 22:365-373. 2006
- In Reply to van der Zee et al. [2]. 22:437-446. 2006
- Untitled - Reply. 22:437-446. 2006
- ROS production and angiogenic regulation by macrophages in response to heat therapy.. 22:263-273. 2006
- Hyperthermia mediated liposomal drug delivery.. 22:205-213. 2006
- Prospective thermal dosimetry: the key to hyperthermia's future.. 22:247-253. 2006
- Characterization of a recombinant adenovirus vector encoding heat-inducible feline interleukin-12 for use in hyperthermia-induced gene-therapy.. 22:117-134. 2006
- Intra-peritoneal cisplatin and whole abdomen hyperthermia for relapsed ovarian carcinoma.. 22:161-172. 2006
- Re-setting the biologic rationale for thermal therapy.. 21:779-790. 2005
- Thermal medicine, heat shock proteins and cancer.. 21:675-677. 2005
- Improved magnetic resonance thermal imaging by combining proton resonance frequency shift (PRFS) and apparent diffusion coefficient (ADC) data.. 21:657-667. 2005
- Phase I/II trial of intravenous Doxil and whole abdomen hyperthermia in patients with refractory ovarian cancer.. 21:333-347. 2005
- Prospective assessment of quality of life in ovarian cancer patients receiving whole abdomen hyperthermia and liposomal doxorubicin.. 21:349-357. 2005
- Enhanced tumour uptake of radiolabelled antibodies by hyperthermia. Part II: Application of the thermal equivalency equation.. 21:13-27. 2005
- Enhanced tumour uptake of radiolabelled antibodies by hyperthermia: Part I: Timing of injection relative to hyperthermia.. 21:1-11. 2005
- Design and analysis of annular antenna arrays with different reflectors.. 20:625-636. 2004
- Effect of calcitonin gene related peptide vs sodium nitroprusside to increase temperature in spontaneous canine tumours during local hyperthermia.. 20:477-489. 2004
- Ultrasound guided pO2 measurement of breast cancer reoxygenation after neoadjuvant chemotherapy and hyperthermia treatment.. 19:498-506. 2003
- Basic principles of thermal dosimetry and thermal thresholds for tissue damage from hyperthermia.. 19:267-294. 2003
- Carcinogenic effects of hyperthermia.. 19:236-251. 2003
- Summary, conclusions and recommendations: adverse temperature levels in the human body.. 19:373-384. 2003
- Effects of cell damage and glycosaminoglycan degradation on available extravascular space of different dextrans in a rat fibrosarcoma.. 19:154-164. 2003
- Hyperthermia-regulated immunogene therapy.. 18:586-596. 2002
- Hyperthermia and the Immune System. 18:485. 2002
- A method of MRI-based thermal modelling for a RF phased array.. 17:465-482. 2001
- Variations of focal regions versus numbers and positions of sources in two-dimensional media.. 17:382-400. 2001
- A phase II trial testing the thermal dose parameter CEM43 degrees T90 as a predictor of response in soft tissue sarcomas treated with pre-operative thermoradiotherapy.. 17:283-290. 2001
- 3D numerical reconstruction of the hyperthermia induced temperature distribution in human sarcomas using DE-MRI measured tissue perfusion: validation against non-invasive MR temperature measurements.. 17:221-239. 2001
- Using units of CEM 43 degrees C T90, local hyperthermia thermal dose can be delivered as prescribed.. 16:415-428. 2000
- Experimental evaluation of the thermal properties of two tissue equivalent phantom materials.. 15:509-518. 1999
- Tumour cell kinetics as predictors of response in canine lymphoma treated with chemotherapy alone or combined with whole body hyperthermia.. 15:475-486. 1999
- Hyperthermia and liposomes.. 15:345-370. 1999
- Use of whole body hyperthermia as a method to heat inaccessible tumours uniformly: a phase III trial in canine brain masses.. 15:383-398. 1999
- Electromagnetic thermal therapy power optimization for multiple source applicators.. 15:291-308. 1999
- Where there's smoke, is there fire?. 14:589-591. 1998
- Further justification for development of non-invasive thermometry.. 14:255. 1998
- A local hyperthermia treatment which enhances antibody uptake in a glioma xenograft model does not affect tumour interstitial fluid pressure.. 13:307-316. 1997
- Phase I evaluation of mitoxantrone alone and combined with whole body hyperthermia in dogs with lymphoma.. 12:309-320. 1996
- Estimation of cell survival in tumours heated to nonuniform temperature distributions.. 12:223-239. 1996
- Estimation of cell survival in tumours heated to nonuniform temperature distributions.. 12:303-304. 1996
- Editorial. 12:1-2. 1996
- Editorial Comment. 12:209-210. 1996
- Hyperthermia treatment planning and temperature distribution reconstruction: a case study.. 12:65-76. 1996
- Simulation of electromagnetically induced hyperthermia: a finite element gridding method.. 11:797-808. 1995
- Verification of a hyperthermia model method using MR thermometry.. 11:409-424. 1995
- Hyperthermic modulation of radiolabelled antibody uptake in a human glioma xenograft and normal tissues.. 11:59-72. 1995
- Effect of whole body hyperthermia on carboplatin disposition and toxicity in dogs.. 10:807-816. 1994
- Application of new technology in clinical hyperthermia.. 10:389-394. 1994
- Future directions in hyperthermia biology.. 10:339-345. 1994
- Hyperthermic sensitization by the radical initiator 2,2'-azobis (2-amidinopropane) dihydrochloride (AAPH). I. In vitro studies.. 10:271-281. 1994
- Dedication of the special issue of the International Journal of Hyperthermia honouring the retirement of George M. Hahn PhD. 10:307-308. 1994
- Manipulation of intra- and extracellular pH in spontaneous canine tumours by use of hyperglycaemia.. 9:745-754. 1993
- Modelling aperture antennas in the near- and far-field regions using subarrays of equivalent uniformly illuminated apertures.. 9:37-49. 1993
- Non-invasive thermometry using magnetic resonance diffusion imaging: potential for application in hyperthermic oncology.. 8:819-829. 1992
- Quantitative estimation of the thermal dose-modifying factor for cis-diamminedichloroplatinum (CDDP) in tumour-bearing dogs.. 8:761-769. 1992
- Response of canine soft tissue sarcomas to radiation or radiation plus hyperthermia: a randomized phase II study.. 8:309-320. 1992
- Effects of glutathione or polyamine depletion on in vivo thermosensitization.. 8:199-208. 1992
- Interstitial microwave-induced hyperthermia and iridium brachytherapy for the treatment of obstructing biliary carcinomas.. 8:157-171. 1992
- On the accuracy of noninvasive thermometry using molecular diffusion magnetic resonance imaging.. 8:263-274. 1992
- Phase III evaluation of doxorubicin and whole-body hyperthermia in dogs with lymphoma.. 8:187-197. 1992
- Enhancement of melphalan-induced gastrointestinal toxicity in mice treated with regional hyperthermia and BSO-mediated glutathione depletion.. 8:111-120. 1992
- Serious toxicity associated with annular microwave array induction of whole-body hyperthermia in normal dogs.. 8:23-32. 1992
- Phase I study of melphalan alone and melphalan plus whole body hyperthermia in dogs with malignant melanoma.. 7:559-566. 1991
- Prediction of heating patterns of a microwave interstitial antenna array at various insertion depths.. 7:197-207. 1991
- The use of hydralazine to manipulate tumour temperatures during hyperthermia.. 6:971-983. 1990
- Clinical experience with a multi-element ultrasonic hyperthermia system: analysis of treatment temperatures.. 6:909-922. 1990
- A comparison of temperatures in canine solid tumours during local and whole-body hyperthermia administered alone and simultaneously.. 6:305-317. 1990
- Blood perfusion measurements in human tumours: evaluation of laser Doppler methods.. 6:287-304. 1990
- Characterization of tumour temperature distributions in hyperthermia based on assumed mathematical forms.. 5:757-777. 1989
- Whole body hyperthermia in dogs using a radiant heating device: effect of surface cooling on temperature uniformity.. 5:137-143. 1989
- A phase I/II study of combined cisplatin and hyperthermia treatment for refractory malignancy.. 5:13-21. 1989
- Stability of temperatures during hyperthermia treatments.. 5:59-67. 1989
- Transient finite element analysis of thermal methods used to estimate SAR and blood flow in homogeneously and nonhomogeneously perfused tumour models.. 4:571-592. 1988
- Cardiovascular and metabolic response of tumour-bearing dogs to whole body hyperthermia.. 3:513-525. 1987
- THERMORADIOTHERAPY OF CANINE TUMORS. 3:565-565. 1987
- WHOLE-BODY HYPERTHERMIA AND CHEMOTHERAPY FOR CANINE LYMPHOMAS. 3:564-565. 1987
- Clinical application of thermal isoeffect dose.. 3:307-318. 1987
- Whole body hyperthermia and heat-sensitizing drugs: a pilot study in canine lymphoproliferative disease.. 3:187-198. 1987
- Effect of hyperthermia on cisplatin pharmacokinetics in normal dogs.. 2:351-358. 1986
- Estimation of therapeutic gain in clinical trials involving hyperthermia and radiotherapy.. 2:165-178. 1986
- Local control and distant metastases in primary canine malignant melanomas treated with hyperthermia and/or radiotherapy.. 1:219-234. 1985